Today: 14 May 2026

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab stock slides today as GMAB shelves acasunlimab; Merus takeout steps in focus

Genmab A/S shares fell 3.3% to $30.44 in New York after the company dropped further development of acasunlimab, a late-stage cancer drug, following a portfolio review. Genmab said the move does not affect its 2025 guidance and will focus on other pipeline drugs. The company also completed its acquisition of Merus N.V., paying $97 per share in a tender offer. Merus requested Nasdaq delist its stock after the merger.
31 December 2025
···
Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla stock today slips as TSLA braces for Q4 deliveries after Tesla posts analyst consensus

Tesla shares slipped 0.2% to $453.58 late Wednesday morning as investors awaited the company’s quarterly deliveries report due Friday. Analyst consensus points to a 13% year-on-year drop in fourth-quarter deliveries, with estimates around 432,810 vehicles. South Korea’s L&F sharply reduced its battery-material supply deal with Tesla, citing lower business tied to Tesla’s battery program.
31 December 2025
···
Meta stock today: META slips after Reuters scam-ad “playbook” report as Manus AI deal stays in focus

Meta stock today: META slips after Reuters scam-ad “playbook” report as Manus AI deal stays in focus

Meta shares fell 0.4% to $663 by late morning Wednesday after a Reuters report said internal documents showed the company delayed tougher ad checks to avoid costs. The U.S. Virgin Islands sued Meta, alleging it profited from scam ads and failed to protect children. Investors are also watching Meta’s planned $2–$3 billion acquisition of AI startup Manus.
31 December 2025
·
Microsoft stock slips in late-morning trade as year-end tech selling weighs on megacaps

Microsoft stock slips in late-morning trade as year-end tech selling weighs on megacaps

Microsoft shares fell 0.5% to $484.89 in late morning trading Wednesday as investors trimmed tech holdings ahead of year-end. Holiday-thin volumes amplified moves in major tech stocks, with Broadcom down 0.7% and Nvidia up 0.7%. Wall Street’s focus remains on the Fed’s Jan. 27-28 meeting and Microsoft’s upcoming earnings, which have not yet been scheduled.
31 December 2025
··
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax’s U.S.-listed shares fell 3.8% to $133.04 late Wednesday morning, reversing part of a recent surge driven by takeover speculation and index inclusion. Trading volume reached about 348,000 shares as the stock swung between $132.13 and $140.25. Investors await updates on strategic interest and new data for obefazimod, the company’s lead drug candidate.
31 December 2025
··
Micron stock slips today as China’s CXMT targets $4.2 billion DRAM IPO

Micron stock slips today as China’s CXMT targets $4.2 billion DRAM IPO

Micron Technology shares fell 1.8% to $287.35 in late-morning New York trading Wednesday after a Reuters report highlighted China’s CXMT plans to raise $4.2 billion for DRAM expansion. Micron’s CFO transferred 35,000 shares to an estate-planning trust, according to a recent filing. The company’s Taiwan unit secured a $149.5 million subsidy for memory chip R&D. Chip stocks and U.S. indexes traded slightly lower.
31 December 2025
···
Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq Keeps PLTS Trading Halted With No Reason Listed as Bengaluru ‘My Room, My Rules’ Row Spreads Online

Nasdaq kept trading in Platinum Analytics Cayman Limited (PLTS) halted Wednesday, listing the reason as “not available” as of 10:23 a.m. ET. The exchange had previously halted PLTS in October after an SEC suspension and requested more information from the company. No further details were provided in the latest notice. Separately, a Bengaluru renter’s late-night noise complaint on Reddit sparked debate over shared-living boundaries.
31 December 2025
·
Why Life360 stock is sliding today as year-end trading hits tech names

Why Life360 stock is sliding today as year-end trading hits tech names

Life360 shares fell 4.4% to $63.79 in morning Nasdaq trading, down $2.94 from Tuesday’s close, with about 108,000 shares changing hands. The drop came as tech stocks extended losses on the final trading day of 2025. Life360 recently raised its full-year revenue outlook and agreed to buy ad-tech firm Nativo for $120 million. The company’s next earnings report is set for Feb. 26.
31 December 2025
···
XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng stock slides 6% today as Chinese EV shares retreat in thin year-end trade

XPeng’s U.S.-listed shares fell 6% to $19.99 by late morning in New York on Wednesday, while NIO dropped 9.5% and Li Auto slid 4.8%. Traders cited thin year-end liquidity and awaited January delivery data and details on China’s updated EV subsidies. XPeng’s ADRs traded between $19.87 and $20.54, with volume near 3.9 million shares. Broader U.S. stocks also slipped ahead of the New Year’s holiday.
31 December 2025
·····
Applied Digital’s ChronoScale plan: Cloud spin-off and Ekso tie-up puts AI GPUs in focus

Applied Digital’s ChronoScale plan: Cloud spin-off and Ekso tie-up puts AI GPUs in focus

Applied Digital will spin out its cloud unit and merge it with Ekso Bionics to form ChronoScale, with Applied owning about 97% of the new company and Ekso shareholders holding about 3%, according to filings. The deal is based on a non-binding term sheet and aims to close in the first half of 2026. Applied Digital shares rose 2.4% after the announcement, while Ekso shares jumped 103%.
31 December 2025
····
1 … 941 942 943 944 945 … 1,932

Stock Market Today

  • NGEx Minerals Shares Surge 12.7% on Lunahuasi Drilling Results and Adit Approval
    May 13, 2026, 8:06 PM EDT. NGEx Minerals (TSX:NGEX) shares rose 12.7% after announcing completion of its Phase 4 drilling program at the Lunahuasi copper-gold-silver project in Argentina, featuring high-grade intersections. The company also secured environmental approval for an underground exploration adit, expanding future drilling and sampling options. These developments support the investment narrative that hinges on assay results shaping the potential scale of deposits at Mars, Saturn, Jupiter, and new zones. Despite the positive news, investor caution remains due to ongoing losses, funding needs, and risks that drill results may not translate into an economic mine. Shares remain volatile with a wide valuation range among analysts, reflecting differing views on exploration success and project risk.

Latest articles

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

14 May 2026
USA Rare Earth reported Q1 revenue of $5.7 million and a net loss of $67 million, ending March with $1.75 billion in cash after a $1.5 billion PIPE. The company expects to sign documents this month for $1.6 billion in U.S. Commerce Department funding. Texas awarded a $14.18 million grant for the Round Top project. USA Rare Earth agreed in April to acquire Brazil’s Serra Verde for $2.8 billion.
Go toTop